Avmapki™ (avutometinib capsules)
for Ovarian Cancer

Avmapki Fakzynja co-pack, a combination of avutometinib and defactinib, each kinase inhibitors, is indicated for the treatment of adult patients with KRAS-mutated recurrent low-grade serous ovarian cancer (LGSOC) who have received prior systemic therapy.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
New Articles Icon New Articles
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Ovarian Cancer